Frequently Asked Questions Is it normal to get a headache when starting semaglutide
While another class of drugs (SGLT2 inhibitors) currently has stronger kidney-specific evidence, GLP-1 drugs appear to provide additional kidney protection, especially in patients with diabetes and obesity.Which categories of Indian patients should actively discuss GLP-1 drugs with their cardiologist
Eli Lilly, which had co-marketed Byetta with Amylin, soon started developing its own GLP-1 compounds (e.g
Off-label prescribing means a doctor prescribes an approved medicine for a use, dose, or population outside what regulators originally approved it for
Possible Side Effects and Risks: Before the trial begins, all potential risks and side effects will be discussed in detail
Ongoing progress monitoring Regular assessments to track body weight changes and overall response to the program